Persistent atrial fibrillation without the evidence of low-voltage areas: a prospective randomized trial
Journal of Interventional Cardiac Electrophysiology · 25.05.2023 · 67 (1) · 83-90
DOI: 10.1007/s10840-023-01564-2 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Interventional Cardiac Electrophysiology, online erschienen am 25.05.2023. Verfasst von Bastian Kaiser und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Robert-Bosch Hospital Stuttgart, Stuttgart, Germany. Hauptthemen laut MEDLINE: Atrial Fibrillation, Pulmonary Veins, Catheter Ablation. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: An effective therapy of persistent atrial fibrillation beyond pulmonary vein isolation remains unsatisfactory. Targeting endocardial low-voltage areas represents an approach of substrate modification. This prospective, randomized study investigated the efficacy of ablation of low-voltage areas versus PVI and additional linear ablations in patients with persistent atrial fibrillation in terms of single-procedure arrhythmia-free outcome and safety. METHODS AND RESULTS: A total number of 100 patients undergoing de-novo catheter ablation for persistent AF were randomized in a 1:1 ratio into two different treatment arms: group A: pulmonary vein isolation (PVI) and, if low-voltage areas were present, a substrate modification. Group B: PVI and, if atrial fibrillation persisted, additional ablations, such as linear ablation and/or ablation of non-PV triggers. A total of 50 patients were randomized into each group without significant differences in baseline characteristics. During a mean follow-up of 17.64 ± 4.5 months after a single procedure, 34 (68%) patients of group A were free of arrhythmia recurrence versus 28 (56%) patients in group B (p = ns). In group A, 30 (60%) patients did not show endocardial fibrosis and received solely PVI. Both procedures were performed with a low number of complications; no pericardial effusion or stroke were seen in either group. CONCLUSIONS: A significant proportion of patients with persistent atrial fibrillation do not show low-voltage areas. A total of 70% of the patients receiving solely PVI did not show any recurrence of atrial fibrillation, and therefore, extensive additional ablation should be avoided in de-novo patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Robert-Bosch Hospital Stuttgart, Stuttgart, Germany.
- Department of Cardiology, Robert-Bosch Hospital Stuttgart, Stuttgart, Germany. cathrin.theis@rbk.de.
- Department of Internal Medicine 3, Cardiology/Electrophysiology, Robert Bosch Hospital Stuttgart, Auerbachstr. 101, 7096, Stuttgart, Germany. cathrin.theis@rbk.de.
Zitieren
APA
Kaiser, B., Huber, C., Pirozzolo, G., Maier, P., Bekeredjian, R., & Theis, C. (2023). Persistent atrial fibrillation without the evidence of low-voltage areas: a prospective randomized trial. Journal of Interventional Cardiac Electrophysiology, 67(1), 83-90. https://doi.org/10.1007/s10840-023-01564-2
Vancouver
Kaiser B, Huber C, Pirozzolo G, Maier P, Bekeredjian R, Theis C. Persistent atrial fibrillation without the evidence of low-voltage areas: a prospective randomized trial. Journal of Interventional Cardiac Electrophysiology. 2023;67(1):83-90. doi:10.1007/s10840-023-01564-2
BibTeX
@article{Kaiser2023,
author = {Kaiser, Bastian and Huber, Carola and Pirozzolo, Giancarlo and Maier, Pasqual and Bekeredjian, Raffi and Theis, Cathrin},
title = {Persistent atrial fibrillation without the evidence of low-voltage areas: a prospective randomized trial},
journal = {Journal of Interventional Cardiac Electrophysiology},
year = {2023},
volume = {67},
number = {1},
pages = {83--90},
doi = {10.1007/s10840-023-01564-2}
}
EUVIMED